Search hospitals > Michigan > Novi
Ascension Providence Hospitals - Novi
Claim this profileNovi, Michigan 48374
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
82 reported clinical trials
7 medical researchers
Summary
Ascension Providence Hospitals - Novi is a medical facility located in Novi, Michigan. This center is recognized for care of Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Adenocarcinoma and other specialties. Ascension Providence Hospitals - Novi is involved with conducting 82 clinical trials across 199 conditions. There are 7 research doctors associated with this hospital, such as Susan E. Lyons, Adam M. Forman, Cynthia M. Vakhariya, and Howard R. Terebelo.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
Top PIs
Susan E. LyonsAscension Providence Hospitals - Southfield4 years of reported clinical research
Studies Adenocarcinoma
Studies Colorectal Cancer
20 reported clinical trials
39 drugs studied
Adam M. FormanAscension Providence Hospitals - Southfield4 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
25 reported clinical trials
46 drugs studied
Cynthia M. VakhariyaAscension Providence Hospitals - Southfield9 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
13 reported clinical trials
27 drugs studied
Howard R. TerebeloAscension Providence Hospitals - Southfield1 year of reported clinical research
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
6 reported clinical trials
13 drugs studied
Clinical Trials running at Ascension Providence Hospitals - Novi
Breast Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Gastric Cancer
Pancreatic Cancer
Rectal Cancer
Squamous Cell Carcinoma
Esophageal Cancer
Esophageal Adenocarcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Ascension Providence Hospitals - Novi?
Ascension Providence Hospitals - Novi is a medical facility located in Novi, Michigan. This center is recognized for care of Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Lung Cancer, Adenocarcinoma and other specialties. Ascension Providence Hospitals - Novi is involved with conducting 82 clinical trials across 199 conditions. There are 7 research doctors associated with this hospital, such as Susan E. Lyons, Adam M. Forman, Cynthia M. Vakhariya, and Howard R. Terebelo.